NUAK1

NUAK family SNF1-like kinase 1 also known as AMPK-related protein kinase 5 (ARK5) is an enzyme that in humans is encoded by the NUAK1 gene.[5][6][7]

NUAK1
Identifiers
AliasesNUAK1, ARK5, NUAK family kinase 1
External IDsOMIM: 608130 MGI: 1925226 HomoloGene: 8896 GeneCards: NUAK1
Gene location (Human)
Chr.Chromosome 12 (human)[1]
Band12q23.3Start106,063,340 bp[1]
End106,140,033 bp[1]
Orthologs
SpeciesHumanMouse
Entrez

9891

77976

Ensembl

ENSG00000074590

ENSMUSG00000020032

UniProt

O60285

Q641K5

RefSeq (mRNA)

NM_014840

NM_001004363

RefSeq (protein)

NP_055655
NP_055655.1

NP_001004363

Location (UCSC)Chr 12: 106.06 – 106.14 MbChr 10: 84.37 – 84.44 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Clinical significance

ARK5 is important in tumor malignancy and invasiveness.[8]

Research findings

ARK5 is often overexpressed in multiple myeloma cell lines.[9][10] ARK5 promotes tumor cell survival under regulation by Akt.[8]

ARK5 increases MT1-MMP production.[8] (MT1-MMP activates MMP-2 and MMP-9 which are involved in tumor metastasis.[8])

As a drug target

ON123300 (a CDK4 inhibitor), also inhibits ARK5 and reduces proliferation of multiple myeloma and mantle cell lymphoma cell lines.[9]

Interactions

NUAK1 has been shown to interact with USP9X[11] and Ubiquitin C.[11]

References

  1. GRCh38: Ensembl release 89: ENSG00000074590 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000020032 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Lavin MF, Esumi H (Dec 2002). "Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein" (PDF). J Biol Chem. 278 (1): 48–53. doi:10.1074/jbc.M206025200. PMID 12409306. S2CID 23605132.
  6. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T, Esumi H (Sep 2003). "ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation". Oncogene. 22 (40): 6177–82. doi:10.1038/sj.onc.1206899. PMID 13679856.
  7. "Entrez Gene: NUAK1 NUAK family, SNF1-like kinase, 1".
  8. Suzuki A, Lu J, Kusakai G et al. (2004). "ARK5 is a tumor invasion-associated factor downstream of Akt signaling". Mol. Cell. Biol. 24 (8): 3526–35. doi:10.1128/MCB.24.8.3526-3535.2004. PMC 381626. PMID 15060171.CS1 maint: uses authors parameter (link)
  9. Multi-Target Drug Blocks Myeloma Proliferation. March 2016
  10. Deepak Perumal et al. (2014). "Dual targeting of CDK4 and ARK5 using a novel kinase inhibitor ON123300 is effective in vitro and in vivo in Multiple Myeloma". Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res. 74: 1324. doi:10.1158/1538-7445.AM2014-1324.CS1 maint: uses authors parameter (link)
  11. Al-Hakim, Abdallah K; Zagorska Anna; Chapman Louise; Deak Maria; Peggie Mark; Alessi Dario R (Apr 2008). "Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains" (PDF). Biochem. J. England. 411 (2): 249–60. doi:10.1042/BJ20080067. PMID 18254724.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.